...08:35 AM EST, 02/09/2015 (MT Newswires) -- Canaccord Genuity boosted its price target on Apple ( AAPL ) shares today to $145 from $135. The analyst noted that as Apple ( AAPL) dominated the smartphone market in Q4 and calendar 2014, it's growing iPhone user base should drive steady long-term iPhone sales and strong cash flows.
To produce another cell phone to try to compete against Apple is just plum stupid!!! Jack Ma must be dumber than he looks!
2 medical conferences, one tomorrow and one on Wednesday. They gotta talk up the pipeline after giving lousy guidance at the earnings release. JMO but seems oversold to me.
Some news re RBCC coming into the 3D printing biz could be part of this crapola.....Through its biotech subsidiary, Rainbow Biosciences, RBCC markets and develops new medical and research technology innovations to compete alongside companies such as Biogen Idec Inc. ( BIIB ) , Abbott Laboratories ( ABT ) and Amgen Inc. ( AMGN ) . Rainbow Biosciences acquired an equity interest in n3D in 2012.
Fidelity is best imo. I pay $8 per trade and customer service has been outstanding.
Take a look at this little pharmaceutical. I got in on 12/29 at 1.70 p/s. Wish I'd bot more but never know about these little cheap stocks. They obviously got something going for them. Just do your own dd.
Can't see the reason for the downgrade. Maybe cuz they didn't raise the dividend this time or the news re midstream biz down. Go figure! Argus just reiterated on 2/5 and today JP Morgan goes neutral!
Good ol' Carl helping the cause today!